Analysts think LLY stock price could increase by 34%
Jun 04, 2025, 11:25 AM
4.66%
What does LLY do
Eli Lilly & Co., headquartered in Indianapolis, employs 43,000 staff and develops various pharmaceutical products, including diabetes, oncology, immunology, and neuroscience therapies, alongside radiopharmaceuticals through its subsidiary POINT Biopharma. The company manufactures and distributes products in the U.S., Europe, and Asia.
29 analysts think LLY stock price will increase by 34.29%. The current median analyst target is $1007.25 compared to a current stock price of $750.05. The lowest analysts target is $681.75 and the highest analyst target is $1249.50.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.